163 related articles for article (PubMed ID: 8348073)
61. Natural killer cell anergy to cytokine stimulants in a subgroup of patients with heart failure: relationship to norepinephrine.
Vredevoe DL; Moser DK; Gan XH; Bonavida B
Neuroimmunomodulation; 1995; 2(1):16-24. PubMed ID: 7614255
[TBL] [Abstract][Full Text] [Related]
62. Should alpha interferon be used as primary treatment for hairy cell leukemia? Italian Cooperative Group for Hairy Cell Leukemia.
Capnist G; Federico M; Chisesi T; Resegotti L; Pagnucco G; Castoldi GL; Lamparelli T; Frassoldati A; Guarnaccia C; Leoni P
Leuk Res; 1991; 15(6):419-26. PubMed ID: 1861528
[TBL] [Abstract][Full Text] [Related]
63. Changes in immunological parameters during interleukin 2 and interferon 2 alpha treatment of recurrent renal cell carcinoma and malignant melanoma.
Maxwell W; McDevitt J; Reid I; Sharpe I; Feighery C; Tanner WA; Emmons R; Monson JR
Eur J Surg Oncol; 1993 Jun; 19(3):265-72. PubMed ID: 8314385
[TBL] [Abstract][Full Text] [Related]
64. Strategy for the treatment of hairy cell leukemia.
Porzsolt F; Raghavachar A; Digel W; Raghavachar A; Bartram CR; Heimpel H
Leukemia; 1987 Apr; 1(4):334-7. PubMed ID: 3669758
[TBL] [Abstract][Full Text] [Related]
65. Hairy cell leukaemia: the role of alpha interferon.
Platanias LC; Ratain MJ
Eur J Cancer; 1991; 27 Suppl 4():S53-7. PubMed ID: 1799481
[TBL] [Abstract][Full Text] [Related]
66. Splenectomy following complete response to alpha interferon (IFN) therapy in patients with hairy cell leukemia (HCL): results of the HCL88 protocol. Italian Cooperative Group for the Study of Hairy Cell Leukemia (ICGHCL).
Damasio EE; Frassoldati A
Leuk Lymphoma; 1994; 14 Suppl 1():95-8. PubMed ID: 7820061
[TBL] [Abstract][Full Text] [Related]
67. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
Gotić M; Rolović Z; Radosević N; Draguljac N; Jovanović V; Bogdanović A; Bosković D
Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434
[TBL] [Abstract][Full Text] [Related]
68. Effects of alpha-interferon on MHC unrestricted cytotoxicity in chronic myelogenous leukemia.
Meseri-Delwail A; Delwail V; Brizard A; Goube de Laforest P; Guilhot F; Lecron JC
Biotechnol Ther; 1994; 5(1-2):47-57. PubMed ID: 7703832
[TBL] [Abstract][Full Text] [Related]
69. [Therapeutic effect of interferon-alpha on hairy cell leukemia].
Abe Y; Sakai K; Igarashi T; Ishibashi T; Shiga T; Uchida T; Kariyone S
Rinsho Ketsueki; 1989 Apr; 30(4):535-40. PubMed ID: 2769975
[TBL] [Abstract][Full Text] [Related]
70. Modulation of in vitro porcine natural killer cell activity by recombinant interleukin-1 alpha, interleukin-2 and interleukin-4.
Knoblock KF; Canning PC
Immunology; 1992 Jun; 76(2):299-304. PubMed ID: 1634252
[TBL] [Abstract][Full Text] [Related]
71. Interferon-Beta combined with interleukin-2 restores human natural cytotoxicity impaired in vitro by ionizing radiations.
Franzese O; Tricarico M; Starace G; Pepponi R; Bonmassar L; Cottarelli A; Fuggetta MP
J Interferon Cytokine Res; 2013 Jun; 33(6):308-18. PubMed ID: 23421371
[TBL] [Abstract][Full Text] [Related]
72. Early response to alpha interferon in a patient affected by hairy cell leukemia.
Di Raimondo F; Murolo D; Milone G; Cacciola E; Giustolisi R
Haematologica; 1992; 77(4):355-6. PubMed ID: 1427445
[TBL] [Abstract][Full Text] [Related]
73. Immunomodulation of early engrafted natural killer cells with interleukin-2 and interferon-alpha in autologous stem cell transplantation.
Porrata LF; Inwards DJ; Lacy MQ; Markovic SN
Bone Marrow Transplant; 2001 Oct; 28(7):673-80. PubMed ID: 11704790
[TBL] [Abstract][Full Text] [Related]
74. Effect of cortisol on the native and in vitro induced non-MHC restricted cytotoxicity of large granular lymphocytes.
Matera L; Cardoso E; Veglia F; Cesano A; Bellone G; Vuolo A; Molinatti GM
J Clin Lab Immunol; 1988 Oct; 27(2):77-81. PubMed ID: 3266762
[TBL] [Abstract][Full Text] [Related]
75. Demonstration of the increase in serine esterase-positive T cells in hairy-cell leukemia patients undergoing alpha-interferon therapy.
Wagner L; Goldstone AH; Worman CP
Leukemia; 1989 May; 3(5):373-9. PubMed ID: 2497282
[TBL] [Abstract][Full Text] [Related]
76. Hyperphosphorylation of CD20 in hairy cells. Alteration by low molecular weight B cell growth factor and IFN-alpha.
Genot E; Valentine MA; Degos L; Sigaux F; Kolb JP
J Immunol; 1991 Feb; 146(3):870-8. PubMed ID: 1703183
[TBL] [Abstract][Full Text] [Related]
77. Novel aspects of in vitro IL-2 or IFN-α enhanced NK cytotoxicity of healthy individuals based on NKG2D and CD161 NK cell receptor induction.
Konjević G; Mirjačić Martinović K; Vuletić A; Radenković S
Biomed Pharmacother; 2010 Dec; 64(10):663-71. PubMed ID: 20800424
[TBL] [Abstract][Full Text] [Related]
78. [Primary treatment of hairy cell leukemia with low-dose human recombinant interferon-alpha-2c (Hr-IFn alpha 2c) in comparison with therapy following splenectomy. Interferon (IFn-alpha 2c) in HCL before or after splenectomy].
Pralle H; Zwingers T; Boedewadt S; Bross K; Dörken B; Gamm H; Ho AD; Parwaresch RM; Schmitz N; Papendick U
Onkologie; 1987 Feb; 10(1):5-10. PubMed ID: 3295625
[TBL] [Abstract][Full Text] [Related]
79. Splenectomy, interferon, and treatments of historical interest in hairy cell leukemia.
Habermann TM
Hematol Oncol Clin North Am; 2006 Oct; 20(5):1075-86. PubMed ID: 16990108
[TBL] [Abstract][Full Text] [Related]
80. Hairy cell leukemia. An update on a cohort of 93 patients treated in a single institution. Effects of interferon in patients relapsing after splenectomy and in patients with or without maintenance treatment.
Troussard X; Flandrin G
Leuk Lymphoma; 1994; 14 Suppl 1():99-105. PubMed ID: 7820062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
